Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Keeping up FDA funding

This article was originally published in The Tan Sheet

Executive Summary

The House Sept. 24 approves a continuing resolution to fund most of the federal government, including FDA, at fiscal 2008 appropriation levels through March 6, 2009. The money available to FDA will be calculated on the basis of both the level in its 2008 appropriation and the $150 million added in a supplemental funding package (1"The Tan Sheet" July 7, 2008, In Brief). As of Sept. 26, the Senate was scheduled to vote on the measure on Sept. 27. Without the continuing resolution, funding for the government would cease Oct. 1. As March approaches, Congress likely will pass another continuing resolution to fund the government through the end of fiscal 2009, a staffer notes

You may also be interested in...

Congress’ Omnibus Language Seeks FDA Progress Reports On Spending

Members of Congress want detailed quarterly updates from FDA on how the agency uses its 2009 appropriation, according to a joint explanatory statement accompanying the omnibus spending bill

Additional FDA funds

FDA receives $150 million in additional funding for fiscal 2008 in the Supplemental Appropriations Bill of 2008, H.R. 2642, signed June 30 by President Bush. The appropriation includes $66.8 million for the Center for Food Safety and Applied Nutrition, $28 million for the Center for Drug Evaluation and Research and $12.7 million for the Center of Biologics Evaluation and Research. In an effort led by Pennsylvania Republican Arlen Specter, the Senate initially approved giving FDA $275 million in additional fiscal 2008 funding, including $125 million for food protection, but the administration vowed to veto those elevated spending levels (1"The Tan Sheet" May 26, 2008, In Brief). Meantime, House appropriators look for progress on fiscal 2009 appropriations despite partisan differences (see story, p. 9)...

Are Trial Sponsors Treading On Investigators’ Toes In Decentralized Trials?

The Danish regulator’s experience with reviewing and inspecting decentralized elements in clinical trials highlights concerns around the blurring of lines that divide the roles and responsibilities of sponsors and trial investigators.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts